Merck to Pay $671 Million Over Medicaid Charges
675729
The deal will settle claims that Merck overcharged Medicaid programs for four drugs, including Vioxx and Zocor, and resolve allegations of improper marketing to doctors.
543218
Merck and Co  on Wednesday  reported a fourth-quarter loss due to charges related to a  costly settlement related to its withdrawn Vioxx arthritis  drug, but results soundly beat Wall Street expectations.
69399
HealthSouth Corp. has agreed to pay the US government $325 million to settle numerous allegations that the company defrauded Medicare and other government health programs, the Justice Department said yesterday.
86670
Merck agreed yesterday to pay more than $650 million to settle charges that it routinely overbilled the government for its most popular medicines, the arthritis drug Vioxx and the cholesterol drug Zocor, cheating Medicaid out of millions of dollars in discounts over eight years.
35363
MONTREAL : A consumer group in Quebec has sued the pharmaceutical firm Merck in Canada, charging that it kept its pain and arthritis drug Vioxx on the market despite the risk of strokes and heart attacks.
429824
TRENTON, N.J. - Pharmaceutical giant Merck & Co...
532416
UnitedHealth Group Inc., one of the largest providers of health insurance in the United States, has paid $20 million to 37 states in order to settle claims processing problems, according to the New York State Department of Insurance.
138327
Swiss biotech company Addex Pharmaceuticals SA  could receive more than $700 million from Merck & Co Inc  for a licensing deal on its ADX63365 drug for schizophrenia, it said on Thursday.
474629
Merck & Co Inc.  said on  Wednesday it agreed to settle tax disputes with the U.S.  Internal Revenue Service at a net cash cost of about $2.3  billion.
85401
When a Blue Cross and Blue Shield of Massachusetts member suffers a stroke, the giant insurer pays the hospital $7,000 on average to cover the care. Medicaid pays an average of $5,441.27.
15688
Merck agreed to pay a Swiss company, Addex Pharmaceuticals, as much as $702 million to help develop a new schizophrenia drug.
646011
Drugmaker Merck &amp; Co., under financial siege since pulling its top painkiller Vioxx off the market in September, said Monday it has adopted a plan that
751178
ZURICH/FRANKFURT  - German drugmaker Merck KGaA   MRCG.DE on Thursday unveiled a surprise 16.6-billion-Swiss   franc ($13.26-billion) deal to buy Swiss biotech firm Serono,   creating a new force in European pharmaceuticals.
33864
A settlement of an inquiry into Lillyâs marketing of the antipsychotic drug Zyprexa could result in the companyâs paying more than $1 billion to federal and state governments.
721172
Since 1992 when the Food and Drug Administration began charging &quot;user fees&quot; to drug companies seeking FDA approval, the agency has received more than $825 million in payments for its services.
377994
Drugmaker Merck & Co. Inc.  boosted its 2007 earnings forecast on Wednesday, citing better-than-expected sales of multiple products, including its cancer vaccine Gardasil and diabetes drug Januvia.
156669
Drugs giant Merck & Co. which pulled  its blockbuster painkiller Vioxx from shelves in September, is  about to become the target of hundreds of plaintiffs' lawyers,  the New York Times reported on Friday.